Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/06/2000 | WO2000000623A1 Hmp-p kinase and tmp-ppase from arabidopsis thaliana and their use in herbicide screening |
01/06/2000 | WO2000000622A2 Human oxidoreductase proteins |
01/06/2000 | WO2000000621A1 Adh7 nucleotides |
01/06/2000 | WO2000000620A2 Dna encoding methymycin and pikromycin |
01/06/2000 | WO2000000619A2 MATERIALS AND METHODS FOR THE ALTERATION OF ENZYME AND ACETYL CoA LEVELS IN PLANTS |
01/06/2000 | WO2000000618A2 Polyketides and their synthesis |
01/06/2000 | WO2000000617A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
01/06/2000 | WO2000000616A2 Marburg virus vaccines |
01/06/2000 | WO2000000615A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
01/06/2000 | WO2000000614A2 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) |
01/06/2000 | WO2000000613A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
01/06/2000 | WO2000000612A1 A novel human thrombopoietin mutein |
01/06/2000 | WO2000000611A2 14273 receptor, a g-protein coupled receptor |
01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
01/06/2000 | WO2000000609A2 Molecules associated with apoptosis |
01/06/2000 | WO2000000608A2 Immune system molecules |
01/06/2000 | WO2000000607A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
01/06/2000 | WO2000000606A1 Npy-y7 receptor gene |
01/06/2000 | WO2000000605A1 Tmprss2 is a tumor suppressor |
01/06/2000 | WO2000000604A1 Methods and compositions for modulating spermatogenesis |
01/06/2000 | WO2000000603A2 Modularly constructed rna molecules having two sequence region types |
01/06/2000 | WO2000000602A1 Novel gaba-b receptor |
01/06/2000 | WO2000000601A2 Production of low-temperature, salt-and drought-tolerant transgenic cereal plants |
01/06/2000 | WO2000000600A2 Lentiviral vectors, comprising modified major donor splice sites and major packaging signals |
01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
01/06/2000 | WO2000000598A2 Plant dwarfing |
01/06/2000 | WO2000000597A2 Non-symbiotic plant hemoglobins to maintain cell energy status |
01/06/2000 | WO2000000594A2 Human transferases |
01/06/2000 | WO2000000593A2 Sphingolipid-desaturase |
01/06/2000 | WO2000000592A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
01/06/2000 | WO2000000591A1 Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production |
01/06/2000 | WO2000000589A1 High-efficiency aav helper functions |
01/06/2000 | WO2000000585A2 MAIZE CYTOCHROME P450 MONOOXYGENASE cDNA (CYP71C3v2) |
01/06/2000 | WO2000000515A2 A CHEMOKINE RECEPTOR OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN |
01/06/2000 | WO2000000513A1 The human gene krab-np (npaawe05) |
01/06/2000 | WO2000000510A2 Growth factor modulators |
01/06/2000 | WO2000000506A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
01/06/2000 | WO2000000504A1 Antisense modulation of tnfr1 expression |
01/06/2000 | WO2000000502A1 MAIZE CYTOCHROME P450 MONOOXYGENASE cDNA (CYP71C3v2) |
01/06/2000 | WO2000000500A2 Polyketides and their synthesis |
01/06/2000 | WO2000000499A1 Method for preparing oligonucleotides with boranophosphate linkages |
01/06/2000 | WO2000000202A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
01/06/2000 | WO2000000161A2 Methods for identification of tef-3 interacting factors |
01/06/2000 | WO1999058656A3 Sustained dna delivery from structural matrices |
01/06/2000 | WO1999057270A3 Human receptor molecules |
01/06/2000 | WO1999056663A3 Stent with smooth ends |
01/06/2000 | WO1999055900A3 Gcp |
01/06/2000 | WO1999055874A3 Nucleic acids of the m antigen gene of histoplasma capsulatum, antigens, vaccines and antibodies, methods and kits for detecting histoplasmosis |
01/06/2000 | WO1999055855A3 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
01/06/2000 | WO1999055841A3 Process for obtaining stem cells |
01/06/2000 | WO1999055364A3 Proteins that direct the secretion of virulence proteins and vaccines comprising them |
01/06/2000 | WO1999054490A3 Plant-derived resistance gene |
01/06/2000 | WO1999051730A3 Mammalian gene encoding tolloid-like protein |
01/06/2000 | WO1999051185A3 Human galactosyl transferases |
01/06/2000 | WO1999049063B1 Protein expression in floral cells |
01/06/2000 | WO1999047661A3 Production of biofilaments in transgenic animals |
01/06/2000 | WO1999044629A3 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
01/06/2000 | WO1999043829A3 Cell cycle related proteins |
01/06/2000 | WO1999029902A9 Method for creating polynucleotide and polypeptide sequences |
01/06/2000 | WO1999029310A3 Regulation of t cell-mediated immunity by tryptophan and its analogs |
01/06/2000 | WO1999026663A3 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
01/06/2000 | WO1998001460A8 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
01/06/2000 | CA2337999A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
01/06/2000 | CA2336554A1 Marburg virus vaccines |
01/06/2000 | CA2335523A1 Polyketides and their synthesis |
01/06/2000 | CA2333481A1 Lentiviral vectors, comprising modified major donor splice sites and major packaging signals |
01/06/2000 | CA2333254A1 Method for simultaneous identification of differentially expressed mrnas and measurement of relative concentrations |
01/06/2000 | CA2332494A1 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
01/06/2000 | CA2332379A1 Molecules associated with apoptosis |
01/06/2000 | CA2332339A1 Improved method for simultaneous identification of differentially expressed mrnas and measurement of relative concentrations |
01/06/2000 | CA2332181A1 Replication-defective recombinant adenovirus with mutated major late promoter |
01/06/2000 | CA2332175A1 Modularly constructed rna molecules having two sequence region types |
01/06/2000 | CA2332130A1 Production of low-temperature, salt-and drought-tolerant transgenic cereal plants |
01/06/2000 | CA2332129A1 Dna encoding methymycin and pikromycin |
01/06/2000 | CA2332121A1 Methods for inhibiting tef-3 activity |
01/06/2000 | CA2331927A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
01/06/2000 | CA2331926A1 Methods for generating highly diverse libraries |
01/06/2000 | CA2331887A1 Novel gaba-b receptor |
01/06/2000 | CA2331886A1 14273 receptor, a g-protein coupled receptor |
01/06/2000 | CA2331881A1 Hmp-p kinase and tmp-ppase from arabidopsis thaliana and their use in herbicide screening |
01/06/2000 | CA2331845A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
01/06/2000 | CA2331779A1 Methods and compositions for modulating spermatogenesis |
01/06/2000 | CA2331762A1 Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production |
01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
01/06/2000 | CA2331380A1 Human oxidoreductase proteins |
01/06/2000 | CA2331334A1 Human proteins having hydrophobic domains and dnas encoding these proteins |
01/06/2000 | CA2331331A1 Method to determine predisposition to hypertension |
01/06/2000 | CA2331328A1 Npy-y7 receptor gene |
01/06/2000 | CA2331327A1 Materials and methods for the alteration of enzyme and acetyl coa levels in plants |
01/06/2000 | CA2330565A1 Growth factor modulators |
01/06/2000 | CA2330546A1 Immune system molecules |
01/06/2000 | CA2330525A1 Human transferases |
01/06/2000 | CA2329264A1 Novel antigens of helicobacter pylori |
01/06/2000 | CA2328499A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
01/06/2000 | CA2301856A1 Fatty acid hydroperoxide lyase nucleic acid sequences |
01/06/2000 | CA2301024A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
01/05/2000 | EP0969103A2 Parallel primer extension approach to nucleic acid sequence analysis |
01/05/2000 | EP0969102A2 Selective restriction fragment amplification: a general method for DNA fingerprinting |
01/05/2000 | EP0969100A1 Method for screening heat shock protein expression induction regulators |
01/05/2000 | EP0969099A2 Ammonia elimination liquid reagent |